Honor Health Research and Innovation Institute

Public research footprint of Honor Health Research and Innovation Institute, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Most-studied conditions

Non-Small Cell Lung Cancer · Long QT Syndrome (LQTS) 2 · Refractory Malignant Solid Neoplasm · Synovial Sarcomas

Recently updated registry entries

NCT05227326 — AOH1996 for the Treatment of Refractory Solid Tumors (Recruiting)
NCT07277582 — Evaluation of Efficacy and Safety of THRV-1268 in Long QT Syndrome Type 2 (LQTS 2) (Recruiting)

Work at Honor Health Research and Innovation Institute?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.